Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Neonatology

Background:

• Preterm labor remains a significant concern in obstetric care.
• Tocolytic agents are used to arrest preterm labor, but their maintenance efficacy is debated.
• Nifedipine is a commonly used calcium channel blocker for tocolysis.

Purpose of the Study:

• To evaluate the efficacy of maintenance nifedipine tocolysis in prolonging gestation.
• To assess the impact of maintenance nifedipine on neonatal outcomes.
• To compare nifedipine with placebo in a randomized controlled trial setting.

Main Methods:

• Prospective, randomized, double-blind, multicenter study.
• Patients with arrested preterm labor received either nifedipine or placebo maintenance therapy.
• Primary outcome was reaching 37 weeks of gestation; neonatal outcomes were also analyzed.

Main Results:

• No significant difference in reaching 37 weeks of gestation between nifedipine and placebo groups (39% vs. 37%).
• Mean delay of delivery was similar between groups (33.5 days vs. 32.6 days).
• No significant differences in neonatal outcomes were observed.

Conclusions:

• Maintenance nifedipine tocolysis after arrested preterm labor does not significantly prolong pregnancy.
• This treatment approach did not demonstrate a substantial reduction in preterm birth rates.
• Neonatal outcomes were not improved with maintenance nifedipine therapy.